BEAM Q1 2020 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000

Gross Profit

-$22M-359050.0% margin

Operating Income

-$28M-472583.3% margin

Net Income

-$30M-507633.3% margin

EPS (Diluted)

$-0.99

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$323M

Total Liabilities

$61M

Stockholders' Equity

$261M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$0	—
Gross Profit	-$22M	-$9M	-134.7%
Operating Income	-$28M	-$13M	-116.3%
Net Income	-$30M	-$14M	-123.8%